Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F67F2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,936
Award facts
- Contract value 100% obligated
- $16,936.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,936 to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens with a completion date of February 2, 2026. This non-set-aside contract employs firm fixed-price pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems with a comprehensive range of pharmaceutical products and medical supplies.
This delivery order falls within AmerisourceBergen's established pharmaceutical supply relationship with the Defense Logistics Agency, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The parent company, Cencora, Inc., operates under the AmerisourceBergen brand and holds the broader indefinite delivery contract with DLA Troop Support Medical, positioning the organization as a single-award primary vehicle for delivering essential pharmaceutical and medical commodities to military treatment facilities and federal healthcare programs worldwide. The firm fixed-price structure and rapid completion timeline reflect the efficiency of the delivery order mechanism for fulfilling urgent pharmaceutical supply needs within the Defense Health Agency and broader military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F67F2?
SPE2DR26F67F2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F67F2 worth?
The government has obligated $16,936 on SPE2DR26F67F2.
Is contract SPE2DR26F67F2 an order under another contract?
Yes. SPE2DR26F67F2 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67F2 competed?
The extent of competition for SPE2DR26F67F2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award